renal failure
Conditions
Interventions
Sponsors
The Second Hospital of Tianjin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with stage 5 chronic kidney disease (CKD) in accordance with the Kidney Disease Outcomes Quality Initiative (KDOQI) and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines; 2.Patients receiving regular maintenance dialysis; 3.Patients for whom autogenous arteriovenous fistula (AVF) is planned or being used as the sole vascular access, in compliance with the 2019 KDOQI Clinical Practice Guidelines for Vascular Access; 4.Age >= 18 years; 5.Patients who have provided written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients receiving irregular dialysis; 2.Patients with high-output states such as hyperthyroidism; 3.Patients scheduled to undergo renal transplantation in the near future; 4.Patients who are currently enrolled in, or expected to participate in, any other clinical trials involving drugs, medical devices, or biological agents during the study period; 5.Patients with unstable vital signs; 6.Patients complicated with malignant tumors or with an expected survival time of less than 1 year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac uhrasonography data; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac troponin I;N-terminal pro-B-type natriuretic peptide;Evaluation of pressure-related parameters of the fistula opening; | — |
Countries
China
Contacts
Public ContactLan Jia
The Second Hospital of Tianjin Medical University
Outcome results
None listed